Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Bristol-Myers Squibb
Bristol-Myers Squibb
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Bristol-Myers Squibb
Trishula Therapeutics, Inc.
Eli Lilly and Company
NGM Biopharmaceuticals, Inc
EpicentRx, Inc.
Spanish Lung Cancer Group
National Cancer Institute (NCI)
EMD Serono
Eli Lilly and Company
Hoffmann-La Roche
Cantargia AB
EMD Serono
Canadian Cancer Trials Group
Cantargia AB
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
AIO-Studien-gGmbH
University of Alabama at Birmingham
Intergroupe Francophone de Cancerologie Thoracique
Bristol-Myers Squibb
Eli Lilly and Company
Incyte Corporation
Case Comprehensive Cancer Center
Bayer
Spanish Lung Cancer Group
Merck Sharp & Dohme LLC
Merck KGaA, Darmstadt, Germany
SCRI Development Innovations, LLC
National Cancer Center, Korea
Bristol-Myers Squibb
Bristol-Myers Squibb
Eli Lilly and Company
Gilead Sciences
SWOG Cancer Research Network
Tianjin Medical University Cancer Institute and Hospital
Eli Lilly and Company
PharmaMar
Eli Lilly and Company
Eli Lilly and Company
Celgene
Hospices Civils de Lyon
Swiss Cancer Institute
Mayo Clinic
AGC Biologics S.p.A.
Wake Forest University Health Sciences